These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 29880818)
1. Aberrant mannosylation profile and FTX/miR-342/ALG3-axis contribute to development of drug resistance in acute myeloid leukemia. Liu B; Ma X; Liu Q; Xiao Y; Pan S; Jia L Cell Death Dis; 2018 Jun; 9(6):688. PubMed ID: 29880818 [TBL] [Abstract][Full Text] [Related]
2. LncRNA MEG3 contributes to drug resistance in acute myeloid leukemia by positively regulating ALG9 through sponging miR-155. Yu Y; Kou D; Liu B; Huang Y; Li S; Qi Y; Guo Y; Huang T; Qi X; Jia L Int J Lab Hematol; 2020 Aug; 42(4):464-472. PubMed ID: 32359033 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA SNHG5 regulates chemotherapy resistance through the miR-32/DNAJB9 axis in acute myeloid leukemia. Wang D; Zeng T; Lin Z; Yan L; Wang F; Tang L; Wang L; Tang D; Chen P; Yang M Biomed Pharmacother; 2020 Mar; 123():109802. PubMed ID: 31884339 [TBL] [Abstract][Full Text] [Related]
4. Knockdown of Long Noncoding RNA HOXA-AS2 Suppresses Chemoresistance of Acute Myeloid Leukemia via the miR-520c-3p/S100A4 Axis. Dong X; Fang Z; Yu M; Zhang L; Xiao R; Li X; Pan G; Liu J Cell Physiol Biochem; 2018; 51(2):886-896. PubMed ID: 30466095 [TBL] [Abstract][Full Text] [Related]
5. TUG1 confers Adriamycin resistance in acute myeloid leukemia by epigenetically suppressing miR-34a expression via EZH2. Li Q; Song W; Wang J Biomed Pharmacother; 2019 Jan; 109():1793-1801. PubMed ID: 30551433 [TBL] [Abstract][Full Text] [Related]
6. Silencing LINC00987 ameliorates adriamycin resistance of acute myeloid leukemia via miR-4458/HMGA2 axis. Liu Y; Zhu XY; Liao LL; Zhang ZH; Huang TS; Zhang L; Jiang XW; Ma Y Biol Direct; 2024 Jun; 19(1):49. PubMed ID: 38910243 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA UCA1 modulates cell proliferation and apoptosis by regulating miR-296-3p/Myc axis in acute myeloid leukemia. Li J; Wang M; Chen X Cell Cycle; 2020 Jun; 19(12):1454-1465. PubMed ID: 32286143 [TBL] [Abstract][Full Text] [Related]
8. Silencing long non-coding RNA XIST suppresses drug resistance in acute myeloid leukemia through down-regulation of MYC by elevating microRNA-29a expression. Wang C; Li L; Li M; Wang W; Liu Y; Wang S Mol Med; 2020 Nov; 26(1):114. PubMed ID: 33228517 [TBL] [Abstract][Full Text] [Related]
9. High expression of long intergenic non-coding RNA LINC00662 contributes to malignant growth of acute myeloid leukemia cells by upregulating ROCK1 via sponging microRNA-340-5p. Liu Y; Gao X; Tian X Eur J Pharmacol; 2019 Sep; 859():172535. PubMed ID: 31306637 [TBL] [Abstract][Full Text] [Related]
10. CircPTK2 promotes cell viability, cell cycle process, and glycolysis and inhibits cell apoptosis in acute myeloid leukemia by regulating miR-582-3p/ALG3 axis. Shang Z; Ming X; Wu J; Liu W; Xiao Y Expert Rev Hematol; 2022 Dec; 15(12):1073-1083. PubMed ID: 35980117 [TBL] [Abstract][Full Text] [Related]
11. Knockdown of LncRNA CRNDE suppresses proliferation and P-glycoprotein-mediated multidrug resistance in acute myelocytic leukemia through the Wnt/β-catenin pathway. Kang Y; Zhang S; Cao W; Wan D; Sun L Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32426817 [TBL] [Abstract][Full Text] [Related]
12. Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a/hexokinase 2 pathway. Zhang Y; Liu Y; Xu X J Cell Biochem; 2018 Jul; 119(7):6296-6308. PubMed ID: 29663500 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA SBF2-AS1 act as a ceRNA to modulate cell proliferation via binding with miR-188-5p in acute myeloid leukemia. Tian YJ; Wang YH; Xiao AJ; Li PL; Guo J; Wang TJ; Zhao DJ Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1730-1737. PubMed ID: 31062614 [TBL] [Abstract][Full Text] [Related]
14. Increased fucosylation has a pivotal role in multidrug resistance of breast cancer cells through miR-224-3p targeting FUT4. Feng X; Zhao L; Gao S; Song X; Dong W; Zhao Y; Zhou H; Cheng L; Miao X; Jia L Gene; 2016 Mar; 578(2):232-41. PubMed ID: 26701615 [TBL] [Abstract][Full Text] [Related]
15. miR-181b increases drug sensitivity in acute myeloid leukemia via targeting HMGB1 and Mcl-1. Lu F; Zhang J; Ji M; Li P; Du Y; Wang H; Zang S; Ma D; Sun X; Ji C Int J Oncol; 2014 Jul; 45(1):383-92. PubMed ID: 24756163 [TBL] [Abstract][Full Text] [Related]
16. Long Non-Coding RNA (LncRNA) Urothelial Carcinoma Associated 1 (UCA1) Increases Multi-Drug Resistance of Gastric Cancer via Downregulating miR-27b. Fang Q; Chen X; Zhi X Med Sci Monit; 2016 Oct; 22():3506-3513. PubMed ID: 27694794 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs. Zebisch A; Hatzl S; Pichler M; Wölfler A; Sill H Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973410 [TBL] [Abstract][Full Text] [Related]
18. Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia. Zhao L; Li Y; Song X; Zhou H; Li N; Miao Y; Jia L Oncotarget; 2016 Sep; 7(37):60074-60086. PubMed ID: 27527856 [TBL] [Abstract][Full Text] [Related]
19. Modification of sialylation is associated with multidrug resistance in human acute myeloid leukemia. Ma H; Zhou H; Song X; Shi S; Zhang J; Jia L Oncogene; 2015 Feb; 34(6):726-40. PubMed ID: 24531716 [TBL] [Abstract][Full Text] [Related]
20. LncRNA KCNQ1OT1 contributes to the progression and chemoresistance in acute myeloid leukemia by modulating Tspan3 through suppressing miR-193a-3p. Sun H; Sun Y; Chen Q; Xu Z Life Sci; 2020 Jan; 241():117161. PubMed ID: 31837329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]